,outcome,arm 1,arm 2
0,intervention,induction,noninduction
0,"incidence of adverse events, cytomegalovirus ( CMV, herpes simplex","17.9 %, 32.5 %","10.1 %, 19.0 %, 3.2 %, 5.7 %, 9.5 %"
0,"incidence of adverse events, total study group","fever ( 25.2 %, leukopenia ( 37.3, thrombocytopenia ( 11.3","fever ( 25.2 %, leukopenia ( 37.3, thrombocytopenia ( 11.3"
